Short-course intensity-modulated radiotherapy for localized prostate cancer with daily transabdominal ultrasound localization of the prostate gland.
暂无分享,去创建一个
[1] G J Kutcher,et al. Variation in prostate position quantitation and implications for three-dimensional conformal treatment planning. , 1997, International journal of radiation oncology, biology, physics.
[2] F. Mauro,et al. Differences in radiation sensitivity in subpopulations of mammalian multicellular systems. , 1979, International journal of radiation oncology, biology, physics.
[3] A. Pollack,et al. External beam radiotherapy for stage T1/T2 prostate cancer: how does it stack up? , 1998, Urology.
[4] G J Kutcher,et al. Three-dimensional conformal radiotherapy and dose escalation: where do we stand? , 1998, Seminars in radiation oncology.
[5] P Kijewski,et al. Analysis of prostate and seminal vesicle motion: implications for treatment planning. , 1996, International journal of radiation oncology, biology, physics.
[6] C. Pelizzari,et al. Evaluation of changes in the size and location of the prostate, seminal vesicles, bladder, and rectum during a course of external beam radiation therapy. , 1995, International journal of radiation oncology, biology, physics.
[7] William R. Fair,et al. DOSE ESCALATION WITH THREE-DIMENSIONAL CONFORMAL RADIATION THERAPY AFFECTS THE OUTCOME IN PROSTATE CANCER , 1998 .
[8] J. Crook,et al. Prostate motion during standard radiotherapy as assessed by fiducial markers. , 1995, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[9] C. Coleman,et al. Analysis of prostate and seminal vesicle motion , 1993 .
[10] D A Jaffray,et al. The effects of intra-fraction organ motion on the delivery of dynamic intensity modulation. , 1998, Physics in medicine and biology.
[11] P. Kupelian. IMPROVEMENT IN OVERALL SURVIVAL FOR PATIENTS WITH LOCALIZED PROSTATE CANCER WITH HIGHER THAN STANDARD RADIATION DOSES: PRELIMINARY RESULTS , 1999 .
[12] E. Klein,et al. Indications for excluding the seminal vesicles when treating clinically localized prostatic adenocarcinoma with radiotherapy alone. , 1997, International Journal of Radiation Oncology, Biology, Physics.
[13] D J Brenner,et al. Fractionation and protraction for radiotherapy of prostate carcinoma. , 1999, International journal of radiation oncology, biology, physics.
[14] J Pouliot,et al. Electronic portal imaging device detection of radioopaque markers for the evaluation of prostate position during megavoltage irradiation: a clinical study. , 1997, International journal of radiation oncology, biology, physics.
[15] J. Lyons,et al. Importance of radiation dose in the treatment of stage T1-T2 adenocarcinoma of the prostate , 1998 .
[16] T E Schultheiss,et al. Survival advantage for prostate cancer patients treated with high-dose three-dimensional conformal radiotherapy. , 1999, The cancer journal from Scientific American.
[17] A. Pollack,et al. External beam radiotherapy dose response of prostate cancer. , 1997, International journal of radiation oncology, biology, physics.
[18] T E Schultheiss,et al. Dose escalation with 3D conformal treatment: five year outcomes, treatment optimization, and future directions. , 1998, International journal of radiation oncology, biology, physics.
[19] M van Herk,et al. Quantification of organ motion during conformal radiotherapy of the prostate by three dimensional image registration. , 1995, International journal of radiation oncology, biology, physics.
[20] H. Levin,et al. Extent of extracapsular extension: Implications for planning for conformal radiotherapy and brachytherapy , 1998 .
[21] G J Kutcher,et al. Locally advanced prostatic cancer: long-term toxicity outcome after three-dimensional conformal radiation therapy--a dose-escalation study. , 1998, Radiology.